[144] Pinterest, Inc. SEC Filing
Form 144 overview: On 06/27/2025 Pinterest, Inc. (NYSE: PINS) filed a Form 144 indicating that corporate officer Wanjiku Juanita Walcott intends to sell up to 11,510 common shares through Charles Schwab & Co. on the NYSE. At the reference value of the filing, the transaction is worth roughly $410,681.
The shares were obtained on 06/20/2025 via a restricted-stock lapse granted as equity compensation. The planned sale is covered by a Rule 10b5-1 trading plan adopted on 08/22/2024, which helps establish that the trade was pre-scheduled.
During the past three months the same insider sold 12,253 Pinterest shares on 03/27/2025, realizing gross proceeds of $395,045. Pinterest reports 594,233,850 shares outstanding, so the proposed 11,510-share sale represents approximately 0.002% of total shares—an amount that is financially immaterial to the company’s capital structure.
Form 144 serves as a notice of intent and does not guarantee the shares will actually be sold. The filer certifies knowledge of no undisclosed material adverse information about Pinterest at the time of filing.
- None.
- None.
Insights
TL;DR: Minor insider sale (0.002% of float); no material impact on PINS valuation.
The proposed sale of 11,510 shares equates to roughly $0.41 million versus Pinterest’s multibillion-dollar market cap. The prior sale of 12,253 shares in March adds context but remains proportionally negligible. Because the trade is executed under a pre-existing Rule 10b5-1 plan, it is less likely to signal information asymmetry. Investors typically watch cumulative insider activity, but this single notice is statistically insignificant to earnings, cash flow, or liquidity metrics. I therefore classify the filing as routine and neutral.
TL;DR: Routine 10b5-1 Form 144 shows compliance; governance risk unchanged.
The use of a dated 10b5-1 plan (08/22/2024) demonstrates procedural adherence and mitigates concerns of opportunistic trading. No new material information is disclosed, and the officer affirms no knowledge of undisclosed adverse data. The amount sold does not trigger aggregation thresholds that could imply control changes. Accordingly, the filing is governance-neutral and not impactful for shareholder oversight.